FDA Seeks Comment On Circumstances For Delaying Denying Limiting Or Refusing An Inspection

By Mark Durivage, Quality Systems Compliance LLC On Dec. 15, 2022, the FDA released for public comment Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection Revision 1. The proposed draft guidance document seeks to update the current guidance document Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug Inspection … Read more